Skip to main content
Key Specialties
Anesthesiology Cardiology Dermatology Diabetology Endocrinology Gastroenterology and Hepatology General Medicine Geriatrics Hematology Infectious Diseases Internal Medicine Nephrology Neurology Obstetrics and Gynecology Oncology Ophthalmology Pediatrics Psychiatry Radiology Respiratory Medicine Rheumatology Surgery Urology
Congress Coverage
ASH 2024 Annual Meeting 2024 ESMO Congress 2024 ERS Congress 2024 EASD Congress 2024 ESC Congress 2024 EAN Congress 2024 ASCO Annual Meeting 2024 ACC Congress
Clinical Collections
Women’s Health Knowledge Hub Advances in Alzheimer’s

Navigating neuroimaging in Alzheimer disease care

PET imaging is playing an increasingly critical role in managing AD, but how can you effectively integrate it into clinical practice? Our expert-led program will empower you with practical strategies and real-world case studies.

This content is intended for healthcare professionals outside of the UK.
ADVANCED SEARCH
Log in
Top
Quality of Life Research
Published in:

Open Access 17-06-2024

Health-related quality of life among older adults following acute hospitalization: longitudinal analysis of a randomized controlled trial

Authors: Eirin Guldsten Robinson, Hanna Gyllensten, Anne Gerd Granas, Kjell H. Halvorsen, Beate Hennie Garcia

Published in: Quality of Life Research | Issue 8/2024

Login to get access

Abstract

Purpose

To describe the longitudinal change of health-related quality of life (HRQoL) over 12 months from acute hospitalization in older adults ≥ 70 years (IMMENSE study), and associated factors, to investigate how a medication optimization intervention influenced this change.

Methods

The EQ-5D-3L was used at discharge and 1, 6 and 12 months after discharge during a randomized controlled trial including 285 participants. Multilevel logistic (EQ-5D-3L dimensions) and mixed model regression (EQ-5D-3L index scores, EQ-VAS) were used to explore the longitudinal change with/without the intervention, and associations with medications, comorbidities, and socioeconomic variables. Subgroup analyses were performed for non-long and long stayers with hospitalizations < or ≥ 14 days.

Results

EQ-5D-3L index scores significantly declined after 12 months (β −0.06 [95% confidence interval (CI:) −0.10–−0.02], p = 0.003). Non-long stayers showed significant improvement 1 month from discharge (β 0.05 [0.00–0.09], p = 0.040). The number of medications and receiving home-care services were the main factors associated with reduced HRQoL. Being home-dwelling was the main factor associated with higher HRQoL. Non-long stayers of the intervention group reported significantly higher EQ-VAS than the control group (β 4.02 [0.11–7.93], p = 0.044).

Conclusion

We observed no significant difference in the longitudinal change in HRQoL between the two IMMENSE study groups over 12 months after hospitalization. However, the non-long stayer subgroup analysis indicates that the intervention may have had a long-term effect on HRQoL in some of intervention patients. The number of medications and the ability to live and care for oneself should be taken into consideration when planning future patient care and health-care services.

Trial registration

The trial was registered in clinicaltrials.gov on 28/06/2016 before enrolment started (NCT02816086).
Appendix
Available only for authorised users
Footnotes
1
Anxiety/Depression dimension: OR1.099 = 2.17 and Usual activities dimension: OR1.24.9 = 6.93.
 
2
EQ-5D-3L index score: β-0.02 × 9 = −0.18 and EQ-VAS: β-1.00 × 9 = −9.
 
Literature
1.
Mangen, M.-J.J., Bolkenbaas, M., Huijts, S. M., van Werkhoven, C. H., Bonten, M. J. M., & de Wit, G. A. (2017). Quality of life in community-dwelling Dutch elderly measured by EQ-5D-3L. Health and Quality of Life Outcomes, 15, 3.CrossRefPubMedPubMedCentral
2.
3.
Montiel-Luque, A., Núñez-Montenegro, A. J., Martín-Aurioles, E., Canca-Sánchez, J. C., Toro-Toro, M. C., González-Correa, J. A., Polipresact Research Group. (2017). Medication-related factors associated with health-related quality of life in patients older than 65 years with polypharmacy. PLoS ONE, 12, e0171320.CrossRefPubMedPubMedCentral
4.
Romskaug, R., Skovlund, E., Straand, J., Molden, E., Kersten, H., Pitkala, K., Lundqvist, C., & Wyller, T. B. (2020). Effect of clinical geriatric assessments and collaborative medication reviews by geriatrician and family physician for improving health-related quality of life in home-dwelling older patients receiving polypharmacy: A cluster randomized clinical trial. JAMA Internal Medicine. https://​doi.​org/​10.​1001/​jamainternmed.​2019.​5096CrossRefPubMed
5.
6.
Wilk, P., Ruiz-Castell, M., Stranges, S., et al. (2023). Relationship between multimorbidity, functional limitation, and quality of life among middle-aged and older adults: Findings from the longitudinal analysis of the 2013–2020 Survey of Health, Ageing, and Retirement in Europe (SHARE). Qual Life Res Int J Qual Life Asp Treat Care Rehabil. https://​doi.​org/​10.​1007/​s11136-023-03508-9CrossRef
7.
Wallace, E., McDowell, R., Bennett, K., Fahey, T., & Smith, S. M. (2017). Impact of potentially inappropriate prescribing on adverse drug events, health related quality of life and emergency hospital attendance in older people attending general practice: A prospective cohort study. Journals of Gerontology. Series A, Biological Sciences and Medical Sciences, 72, 271–277.CrossRefPubMed
8.
O’Connor, M. N., O’Sullivan, D., Gallagher, P. F., Eustace, J., Byrne, S., & O’Mahony, D. (2016). Prevention of hospital-acquired adverse drug reactions in older people using screening tool of older persons’ prescriptions and screening tool to alert to right treatment criteria: A cluster randomized controlled trial. Journal of the American Geriatrics Society, 64, 1558–1566.CrossRefPubMed
9.
O’Sullivan, D., O’Mahony, D., O’Connor, M. N., Gallagher, P., Gallagher, J., Cullinan, S., O’Sullivan, R., Eustace, J., & Byrne, S. (2016). Prevention of adverse drug reactions in hospitalised older patients using a software-supported structured pharmacist intervention: A cluster randomised controlled trial. Drugs and Aging, 33, 63–73.CrossRefPubMed
10.
Lea, M., Mowé, M., Molden, E., Kvernrød, K., Skovlund, E., & Mathiesen, L. (2020). Effect of medicines management versus standard care on readmissions in multimorbid patients: A randomised controlled trial. British Medical Journal Open, 10, e041558.
11.
Gillespie, U., Alassaad, A., Henrohn, D., Garmo, H., Hammarlund-Udenaes, M., Toss, H., Kettis-Lindblad, A., Melhus, H., & Mörlin, C. (2009). A comprehensive pharmacist intervention to reduce morbidity in patients 80 years or older: A randomized controlled trial. Archives of Internal Medicine, 169, 894–900.CrossRefPubMed
12.
13.
Rankin, A., Cadogan, C. A., In Ryan, C., Clyne, B., Smith, S. M., & Hughes, C. M. (2018). Core outcome set for trials aimed at improving the appropriateness of polypharmacy in older people in primary care. Journal of the American Geriatrics Society, 66, 1206–1212.CrossRefPubMed
14.
Beuscart, J.-B., Knol, W., Cullinan, S., et al. (2018). International core outcome set for clinical trials of medication review in multi-morbid older patients with polypharmacy. BMC Medicine, 16, 21.CrossRefPubMedPubMedCentral
15.
Johansen, J. S., Havnes, K., Halvorsen, K. H., Haustreis, S., Skaue, L. W., Kamycheva, E., Mathiesen, L., Viktil, K. K., Granås, A. G., & Garcia, B. H. (2018). Interdisciplinary collaboration across secondary and primary care to improve medication safety in the elderly (IMMENSE study): Study protocol for a randomised controlled trial. British Medical Journal Open, 8, e020106.
16.
Johansen, J. S., Halvorsen, K. H., Svendsen, K., Havnes, K., Robinson, E. G., Wetting, H. L., Haustreis, S., Småbrekke, L., Kamycheva, E., & Garcia, B. H. (2022). Interdisciplinary collaboration across secondary and primary care to improve medication safety in the elderly (The IMMENSE study)—a randomized controlled trial. BMC Health Services Research, 22, 1290.CrossRefPubMedPubMedCentral
17.
Johansen, J. S., Halvorsen, K. H., Havnes, K., Wetting, H. L., Svendsen, K., & Garcia, B. H. (2022). Intervention fidelity and process outcomes of the IMMENSE study, a pharmacist-led interdisciplinary intervention to improve medication safety in older hospitalized patients. Journal of Clinical Pharmacy and Therapeutics, 47, 619–627.CrossRefPubMed
18.
19.
20.
21.
Hosmer, D. W., & Lemeshow, S. (2013). Sturdivant RX Applied Logistic Regression (3rd ed.). John Wiley & Sons.CrossRef
22.
Griffiths, A., Paracha, N., Davies, A., Branscombe, N., Cowie, M. R., & Sculpher, M. (2017). Analyzing health-related quality of life data to estimate parameters for cost-effectiveness models: An example using longitudinal EQ-5D data from the SHIFT randomized controlled trial. Advances in Therapy, 34, 753–764.CrossRefPubMedPubMedCentral
23.
Twisk, J., de Boer, M., de Vente, W., & Heymans, M. (2013). Multiple imputation of missing values was not necessary before performing a longitudinal mixed-model analysis. Journal of Clinical Epidemiology, 66, 1022–1028.CrossRefPubMed
24.
Gabrio, A., Plumpton, C., Banerjee, S., & Leurent, B. (2022). Linear mixed models to handle missing at random data in trial-based economic evaluations. Health Economics, 31, 1276–1287.CrossRefPubMedPubMedCentral
25.
Faria, R., Gomes, M., Epstein, D., & White, I. R. (2014). A guide to handling missing data in cost-effectiveness analysis conducted within randomised controlled trials. PharmacoEconomics, 32, 1157–1170.CrossRefPubMedPubMedCentral
26.
StataCorp. (2021). Stata Statistical Software: Release 17. StataCorp LLC.
27.
Stavem, K., Augestad, L. A., Kristiansen, I. S., & Rand, K. (2018). General population norms for the EQ-5D-3 L in Norway: Comparison of postal and web surveys. Health and Quality of Life Outcomes, 16, 204.CrossRefPubMedPubMedCentral
28.
König, H.-H., Heider, D., Lehnert, T., et al. (2010). Health status of the advanced elderly in six european countries: Results from a representative survey using EQ-5D and SF-12. Health and Quality of Life Outcomes, 8, 143.CrossRefPubMedPubMedCentral
29.
König, H.-H., Brettschneider, C., Lühmann, D., et al. (2020). EQ-5D-3L health status and health state utilities of the oldest-old (85 +) in Germany: Results from the AgeCoDe-AgeQualiDe study. Qual Life Res Int J Qual Life Asp Treat Care Rehabil, 29, 3223–3232.
30.
Wæhler, I. S., Saltvedt, I., Lydersen, S., Fure, B., Askim, T., Einstad, M. S., & Thingstad, P. (2021). Association between in-hospital frailty and health-related quality of life after stroke: The Nor-COAST study. BMC Neurology, 21, 100.CrossRefPubMedPubMedCentral
31.
Comans, T. A., Peel, N. M., Gray, L. C., & Scuffham, P. A. (2013). Quality of life of older frail persons receiving a post-discharge program. Health and Quality of Life Outcomes, 11, 58.CrossRefPubMedPubMedCentral
32.
Luo, N., Johnson, J., & Coons, S. J. (2010). Using instrument-defined health state transitions to estimate minimally important differences for four preference-based health-related quality of life instruments. Medical Care, 48, 365–371.CrossRefPubMed
33.
Walters, S. J., & Brazier, J. E. (2005). Comparison of the minimally important difference for two health state utility measures: EQ-5D and SF-6D. Qual Life Res Int J Qual Life Asp Treat Care Rehabil, 14, 1523–1532.
34.
Sunde, S., Hesseberg, K., Skelton, D. A., Ranhoff, A. H., Pripp, A. H., Aarønæs, M., & Brovold, T. (2021). Associations between health-related quality of life and physical function in older adults with or at risk of mobility disability after discharge from the hospital. Eur Geriatr Med, 12, 1247–1256.CrossRefPubMedPubMedCentral
35.
36.
Grochtdreis, T., Dams, J., König, H.-H., & Konnopka, A. (2019). Health-related quality of life measured with the EQ-5D-5L: Estimation of normative index values based on a representative German population sample and value set. Eur J Health Econ HEPAC Health Econ Prev Care, 20, 933–944.CrossRef
37.
Janssen, M. F., Szende, A., Cabases, J., Ramos-Goñi, J. M., Vilagut, G., & König, H. H. (2019). Population norms for the EQ-5D-3L: A cross-country analysis of population surveys for 20 countries. Eur J Health Econ HEPAC Health Econ Prev Care, 20, 205–216.CrossRef
38.
Keramat, S. A., Lee, V., Patel, R., Hashmi, R., & Comans, T. (2023). Cognitive impairment and health-related quality of life amongst older Australians: Evidence from a longitudinal investigation. Qual Life Res Int J Qual Life Asp Treat Care Rehabil, 32, 2911–2924.
Metadata
Title
Health-related quality of life among older adults following acute hospitalization: longitudinal analysis of a randomized controlled trial
Authors
Eirin Guldsten Robinson
Hanna Gyllensten
Anne Gerd Granas
Kjell H. Halvorsen
Beate Hennie Garcia
Publication date
17-06-2024
Publisher
Springer International Publishing
Published in
Quality of Life Research / Issue 8/2024
Print ISSN: 0962-9343
Electronic ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-024-03689-x

Other articles of this Issue 8/2024

Patient perspectives and preferences on cerclage and preterm birth: a focus group study

Moving towards increased implementation of evidence-based measurements through comprehensive and transparent reporting: the PRISMA–COSMIN 2024 reporting guideline

  • Letter to the Editor

The dyadic associations among self-efficacy, dyadic coping, and health-related quality of life between high-risk pregnant women and spouses: a cross-sectional study

An investigation of the longitudinal trajectory patterns of health-related quality of life among Australians with disabilities: explaining disability types and properties

  • Open Access

Correction to: The QALY is ableist: on the unethical implications of health states worse than dead

  • Open Access
  • Correction

Assessing uptake of the core outcome set in anxiety disorder clinical trials: a cross-sectional analysis